Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2006 • 2,702 citations

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

2002 • 652 citations

Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor Prognosis

1995 • 430 citations

A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the Bladder

1993 • 367 citations

BACILLUS CALMETTE-GUERIN VERSUS CHEMOTHERAPY FOR THE INTRAVESICAL TREATMENT OF PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER: A META-ANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS

2005 • 366 citations

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.

2001 • 302 citations

Factors affecting recurrence and progression in superficial bladder tumours

1995 • 286 citations

Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.

2002 • 281 citations

Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.

1984 • 273 citations

Association of P53 Nuclear Overexpression and Tumor Progression in Carcinoma in situ of the Bladder

1994 • 221 citations

The Case for Early Cystectomy in the Treatment of Nonmuscle Invasive Micropapillary Bladder Carcinoma

2006 • 216 citations

Original Articles: Bladder Cancer: Intravesical Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Results of 2 European Organization for Research and Treatment of Cancer Randomized Trials With Mitomycin C and Doxorubicin Comparing Early Versus Delayed Instillations and Short-Term Versus Long-Term Treatment

1995 • 171 citations

Prognostic Factors in Superficial Bladder Tumors. A Study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group

1983 • 160 citations

The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers.

2002 • 143 citations

Predictive Value of Cell Cycle Biomarkers in Nonmuscle Invasive Bladder Transitional Cell Carcinoma

2007 • 142 citations

INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIAL

2001 • 140 citations

Treatment of Superficial Bladder Tumors: Achievements and Needs

2000 • 128 citations

Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma : results of 2 european organization for research and treatment of cancer randomized trials with Mitomycin C and Doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment

1995 • 124 citations

Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle‐related nuclear antigen (Ki‐67)

1992 • 108 citations

Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer

1998 • 107 citations

BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER—GENITO-URINARY GROUP PHASE III TRIAL (30906)

2005 • 106 citations

N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors

2006 • 101 citations

Adjuvant Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:Preliminary Results of a European Organization for Research onTreatment of Cancer Randomized Trial Comparing Doxorubicin Hydrochloride, Ethoglucid and Transurethral Resection Alone

1984 • 96 citations

The Prognostic Value of DNA Analysis in Primary Carcinoma in Situ of the Urinary Bladder

1982 • 94 citations

Intravesical BCG in Patients with Carcinoma in situ of the Urinary Bladder: Long–Term Results of EORTC GU Group Phase II Protocol 30861

2001 • 90 citations

Molecular Aspects of Bladder Cancer

2002 • 84 citations

Prophylactic Chemotherapy of Superficial Transitional Cell Bladder Carcinoma: an EORTC Randomized Trial Comparing Thiotepa, an Epipodophyllotoxin (VM26) and TUR Alone

1982 • 84 citations

Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder

1993 • 78 citations

Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder

2006 • 75 citations

Molecular Markers of Urothelial Cancer and Their Use in the Monitoring of Superficial Urothelial Cancer

2006 • 74 citations

Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Long-term Results of a European Organization for Research and Treatment of Cancer Randomized Trial Comparing Doxorubicin, Ethoglucid and Transurethral Resection Alone

1997 • 70 citations

THE ABLATIVE EFFECT OF QUARTER DOSE BACILLUS CALMETTE-GUERIN ON A PAPILLARY MARKER LESION OF THE BLADDER

2001 • 69 citations

Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene

2005 • 66 citations

Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder

2006 • 65 citations

Tryptophan Metabolites, Pyridoxine (Vitamin B(6)) and Their Influence on the Recurrence Rate of Superficial Bladder Cancer

1995 • 62 citations

Expression of E-Cadherin and α-,β-,γ-Catenins in Patients With Bladder Cancer

2006 • 60 citations

Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.

2003 • 59 citations

The Prognostic Value of Cell Surface Antigens in Low Grade, Non-Invasive, Transitional Cell Carcinoma of the Bladder

1979 • 58 citations

Adjuvant Chemotherapy of Recurrent Superficial Transitional Cell Carcinoma: Results of a European Organization for Research on Treatment of Cancer Randomized Trial Comparing Intravesical Instillation of Thiotepa, Doxorubicin and Cisplatin

1992 • 56 citations

The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase‐polymerase chain reaction analysis

2006 • 55 citations

Urinary bladder tumor markers

2006 • 55 citations

Regularly methylated novel pro‐apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder

2006 • 54 citations

Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications

2004 • 53 citations

Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette–Guérin (BCG)

2003 • 49 citations

Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer

1991 • 48 citations

Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder

2006 • 48 citations

Prognostic factors in superficial bladder tumors

1992 • 48 citations

Growth Fractions in Bladder Cancer Defined by Ki67: Association with Cancer Grade, Category and Recurrence Rate of Superficial Lesions

1993 • 47 citations

Molecular prognostication in bladder cancer—a current perspective

2003 • 45 citations

Molecular pathology of non-invasive urothelial carcinomas (part I)

2003 • 40 citations

Prognostic Value of p53 for High Risk Superficial Bladder Cancer With Long-Term Followup

2006 • 37 citations

Image cytometric DNA analysis in transitional cell carcinoma of the bladder

1993 • 36 citations

Marker tumour responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897).

1996 • 36 citations

Transferrin Receptor Expression in Primary Superficial Human Bladder Tumours Identifies Patients who Develop Recurrences

1990 • 35 citations

Cytogenetic Analysis: A Potential Index for Recurrence of Early Carcinoma of the Bladder

1976 • 35 citations

Bladder cancer diagnosis and recurrence prognosis: Comparison of markers with emphasis on survivin

2006 • 31 citations

Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors

2001 • 31 citations

Prognostic significance of angiogenesis in superficial bladder cancer

2004 • 30 citations

Reduced E-cadherin and α-catenin expressions have no prognostic role in bladder carcinoma

2006 • 26 citations

Proliferative state of the urothelium with benign and atypical changes. Correlation with transferrin and epidermal growth factor receptors and blood group antigens

1993 • 23 citations

ARGYROPHILIC NUCLEOLAR ORGANIZER REGION IN PROLIFERATING CELL HAS A PREDICTIVE VALUE FOR LOCAL RECURRENCE IN SUPERFICIAL BLADDER TUMOR

1999 • 19 citations

Expression of E-Cadherin and α-, β-, γ-Catenins in Patients With Bladder Cancer

2005 • 17 citations

Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.

1976 • 15 citations

The diagnostic and prognostic value of urinary polyamine measurement in bladder cancer

1981 • 14 citations

The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer

2006 • 14 citations

Prognostic value of static cytometry in transitional cell carcinoma of the bladder: Recurrence rate and survival in a group of patients at 10 years follow-up

2006 • 13 citations

S‐phase fraction in superficial urothelial carcinoma of the bladderA prospective, long‐term, follow‐up study

2004 • 10 citations

Recent developments in molecular profiling of bladder cancer

2006 • 9 citations

Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm

2003 • 8 citations

The Influence of Retinoic Acid Receptor (RAR) Status of Bladder Tumours on the Course of the Disease

1985 • 7 citations

Association of depressed mixed lymphocyte reactivity with the development of bladder carcinoma in patients with papillomas

1983 • 6 citations

Deleted Work

1955 • 0 citations